Hledání článků
Filtry
Winklemayer C, Fischer MA, Schneeweiss S, et al. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis 2005;46:1080–1087.
Evans M, Fryzek JP, Elinder C-G, et al. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 2005;46:863–870.
Marik PE, Wood K, Starzl T. The course of type 1 hepato-renal syndrome post liver translantation. Nephrol Dial Transpl 2006;21:478–482.
Caramori ML, Fioretto P, Mauer M. Enhacing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol 2006;17:339–352.
Ergün I, Keven K, Uruc I, et al. The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 2006;21:697–700.
Fujii Y, Khoshnoodi J, Takenaka H, et al. The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases. Kidney Int 2006;69:1350–1359.
Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006;69:1222–1228.
Amann K, Haas CS. What you should know about the work-up of a renal biopsy. Nephrol Dial Transplant. 2006;21:1157–1161.
The World Kidney Day – an idea whose time has come. Am J Kidney Dis 2006;47:375–377.
Tonelli M, Keech A, Shepherd J, et al. Effect of pravastatin in people with diabetes and chronic kidney disease. J Am Soc Nephrol 2005;16:3748–3754.
Matsuda H, Fukuda N, Ueno T, et al. Development of gene silencing pyrroleimidazole polyamide targeting the TGF- beta1 promoter for treatment of progressive renal diseases. J Am Soc Nephrol 2006;17:422–432.
Brantsma AH, Bakker SJL, de Zeeuw D, et al. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 2006;17:331–335.
Gore JL, Pham PT, Danovitch GM, Wilkinson AH, Rosenthal JT, Lipshutz GS, Singer JS. Obesity and outcome following renal transplantation. Am J Transplant 2006;6:357–363.
Stegall MD, Gloor J, Winter JL, Moore SB, DeGoey S. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006;6:346–351.